# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016069
Filing Date
2023-05-10
Accepted
2023-05-10 08:30:30
Documents
58
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 930811
2 |  | ex10-1.htm | EX-10.1 | 1842
3 |  | ex31-1.htm | EX-31.1 | 17784
4 |  | ex31-2.htm | EX-31.2 | 14618
5 |  | ex32-1.htm | EX-32.1 | 6944
6 |  | ex32-2.htm | EX-32.2 | 6797
7 |  | ex10-1_001.jpg | GRAPHIC | 765303
8 |  | ex10-1_002.jpg | GRAPHIC | 413524
| Complete submission text file | 0001493152-23-016069.txt |  | 6676573

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL SCHEMA FILE | lixt-20230331.xsd | EX-101.SCH | 40965
10 | XBRL CALCULATION FILE | lixt-20230331_cal.xml | EX-101.CAL | 31676
11 | XBRL DEFINITION FILE | lixt-20230331_def.xml | EX-101.DEF | 197516
12 | XBRL LABEL FILE | lixt-20230331_lab.xml | EX-101.LAB | 328847
13 | XBRL PRESENTATION FILE | lixt-20230331_pre.xml | EX-101.PRE | 250800
52 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 750081

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39717 | Film No.: 23904468
SIC: 2834 Pharmaceutical Preparations